THE DIFFERENCES IN PROGNOSTIC OUTCOME BETWEEN AML1/ETO AND CBFβ/MYH11 POSITIVE AML PATIENTS

被引：0
|
作者：
Markova, J. [1 ]
Michkova, P. [1 ]
Maaloufova, J. Soukupova [1 ]
Soukup, P. [1 ]
Cetkovsky, P. [1 ]
Schwarz, J. [1 ]
机构：
[1] Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0669
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [41] Is AML1/ETO gene expression a good prognostic factor in adult acute myeloblastic leukemia?
    Choi, IS
    Yoon, SS
    Roh, EY
    Lee, DS
    Kwon, JH
    Kim, DW
    Oh, DY
    Lee, JJ
    Joh, YH
    Park, S
    Kim, BK
    Kim, NK
    BLOOD, 2002, 100 (11) : 234B - 234B
  • [42] Is AML1/ETO gene expression a good prognostic factor in pediatric acute myeloblastic leukemia?
    Sarper, N
    Özbek, U
    Agaoglu, L
    Özgen, Ü
    Eryilmaz, E
    Yalman, N
    Anak, S
    Devecioglu, Ö
    Gedikoglu, G
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2000, 17 (07) : 577 - 583
  • [43] DETECTION OF DNA REARRANGEMENTS IN THE AML1 AND ETO LOCI AND OF AN AML1/ETO FUSION MESSENGER-RNA IN PATIENTS WITH T(8-21) ACUTE MYELOID-LEUKEMIA
    NUCIFORA, G
    BIRN, DJ
    ERICKSON, P
    GAO, JZ
    LEBEAU, MM
    DRABKIN, HA
    ROWLEY, JD
    BLOOD, 1993, 81 (04) : 883 - 888
  • [44] Identification of epigenetic modifiers essential for growth and survival of AML1/ETO-positive leukemia
    Duque-Afonso, Jesus
    Veratti, Pia
    Rehman, Usama-Ur
    Herzog, Heike
    Mitschke, Jan
    Greve, Gabriele
    Eble, Julian
    Berberich, Bettina
    Thomas, Johanna
    Pantic, Milena
    Waterhouse, Miguel
    Gentile, Gaia
    Heidenreich, Olaf
    Miething, Cornelius
    Luebbert, Michael
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (11) : 2068 - 2079
  • [45] Treatment with valproic acid restores differentiation in AML1/ETO-positive leukaemic cells
    Zapotocky, Michal
    Starkova, Julia
    Mejstrikova, Ester
    Smetana, Karel
    Trka, Jan
    BLOOD, 2007, 110 (11) : 141B - 141B
  • [46] IN VITRO VALPROIC ACID TREATMENT MODIFIES THE PROTEOME OF AML1/ETO POSITIVE LEUKEMIA CELLS
    Buchi, F.
    Ferrari, G.
    Spinelli, E.
    Gozzini, A.
    Bosi, A.
    Lunghi, T.
    Santini, V
    HAEMATOLOGICA, 2008, 93 : S85 - S85
  • [47] Treatment with valproic acid restores differentiation in AML1/ETO-positive leukaemic cells
    Zapotocky, M.
    Starkova, J.
    Mejstrikova, E.
    Smetana, K.
    Trka, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 42 - 42
  • [48] Identification of Epigenetic Modifiers Essential for Growth and Survival of AML1/ETO-Positive Leukemia
    Afonso, Jesus Duque
    Pia, Veratti
    Rehman, Usama-Ur
    Herzog, Heike
    Mitschke, Jan
    Greve, Gabriele
    Eble, Julian
    Berberich, Bettina
    Thomas, Johanna
    Pantic, Milena
    Waterhouse, Miguel
    Gentile, Gaia
    Heidenreich, Olaf
    Miething, Cornelius
    Luebbert, Michael
    BLOOD, 2023, 142
  • [49] Monitoring the AML1/ETO Fusion Transcript to Predict Outcome in Childhood Acute Myeloid Leukemia
    Zhang, Li
    Cao, Zeng
    Ruan, Min
    Zeng, Qiang
    Zhao, Liang
    Li, Qinghua
    Zou, Yao
    Wang, Jianxiang
    Zhu, Xiaofan
    PEDIATRIC BLOOD & CANCER, 2014, 61 (10) : 1761 - 1766
  • [50] Differing transcriptional activities of AML1-ETO and CBFB-MYH11 fusion proteins on the CBF regulated promoter of CSF1R
    Claxton, DF
    Xie, QS
    Deisseroth, AB
    Chang, KS
    BLOOD, 1995, 86 (10) : 137 - 137
12345